What are the side effects of Selpercatinib?
Selpercatinib is a multikinase inhibitor used to treat certain types of non-small cell lung cancer in adults. Serpatinib is also used to treat certain types of thyroid cancer in adults and children at least 12 years old. Serpatinib is used when the cancer has spread to other parts of the body (metastatic).

Sepretinib/Common side effects of serpatinib includeSTincrease(51%), alanine aminotransferase increase(45%), blood sugar Elevated (44%), Leukopenia(43%), Reduced albumin(42%), Reduced calcium(41%), Dry mouth(39%), Diarrhea(37%), Elevated creatinine(37%), Increased alkaline phosphatase(36%), Hypertension(35%), Fatigue(35%), edema(33%), Platelet count pan>(33%), Increased total cholesterol (31%), Skin rash (27%), Reduced sodium (27%), Constipation (25%), Decreased magnesium levels (24%),
xa0 xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)